Literature
首页医源资料库在线期刊美国临床营养学杂志2007年86卷第3期

GSTT1 genotype modifies the association between cruciferous vegetable intake and the risk of myocardial infarction

来源:《美国临床营养学杂志》
摘要:ABSTRACTBackground:Cruciferousvegetablesareamajordietarysourceofisothiocyanatesthatmayprotectagainstcoronaryheartdisease。Objective:TheobjectiveofthestudywastodeterminewhetherGSTgenotypesmodifytheassociationbetweencruciferousvegetableintakeandtheriskofmyocard......

点击显示 收起

Marilyn C Cornelis, Ahmed El-Sohemy and Hannia Campos

1 From the Department of Nutritional Sciences, University of Toronto, Canada (MCC and AE); the Department of Nutrition, Harvard School of Public Health, Boston, MA (HC); and the Centro Centroamericano de Poblacion, Universidad de Costa Rica San Pedro de Montes de Oca, Costa Rica (HC)

2 Supported by grants from the Canadian Institutes of Health Research (no. MOP-53147) and the National Institutes of Health (HL 60692 and HL 071888) and by a Natural Sciences and Engineering Research Council of Canada postgraduate scholarship (to MCC). AE holds a Canada Research Chair in Nutrigenomics.

3 Reprints not available. Address correspondence to A El-Sohemy, Department of Nutritional Sciences, University of Toronto, Room 350, 150 College Street, Toronto, ON, Canada, M5S 3E2. E-mail: a.el.sohemy{at}utoronto.ca.


ABSTRACT  
Background:Cruciferous vegetables are a major dietary source of isothiocyanates that may protect against coronary heart disease. Isothiocyanates induce glutathione S-transferases (GSTs), polymorphic genes that code for enzymes that conjugate isothiocyanates, as well as mutagens and reactive oxygen species, to make them more readily excretable.

Objective:The objective of the study was to determine whether GST genotypes modify the association between cruciferous vegetable intake and the risk of myocardial infarction (MI).

Design:Cases (n = 2042) with a first acute nonfatal MI and population-based controls (n = 2042) living in Costa Rica, who were matched for age, sex, and area of residence, were genotyped for a deletion polymorphism in GSTM1 and GSTT1 and an Ile105Val substitution in GSTP1. Cruciferous vegetable intake and smoking status were determined by questionnaire. Odds ratios (ORs) and 95% CIs for MI were estimated by unconditional logistic regression.

Results:Compared with the lowest tertile of cruciferous vegetable intake, the highest tertile was associated with a lower risk of MI among persons with the functional GSTT1*1 allele (OR: 0.70; 95% CI: 0.58, 0.84) but not among those with the GSTT1*0*0 genotype (OR: 1.23; 95% CI: 0.83, 1.82) (P = 0.006 for interaction). This protective effect among those with the GSTT1*1 allele was greater for current smokers (OR: 0.54; 95% CI: 0.36, 0.79) than for nonsmokers. GSTP1 and GSTM1 did not modify the association between cruciferous vegetable intake and MI.

Conclusions:Consumption of cruciferous vegetables was associated with a lower risk of MI among those with a functional GSTT1*1 allele, which suggests that compounds that are detoxified by this enzyme contribute to the risk of MI.

Key Words: Cruciferous vegetables • isothiocyanate • glutathione S-transferase • genotype • myocardial infarction


INTRODUCTION  
Atherosclerosis is a major cause of myocardial infarction (MI), one of the leading causes of cardiovascular deaths in the world (1). The American Heart Association recommends 5 servings of fruit and vegetables/d to reduce the risk of chronic diseases such as coronary heart disease (CHD) (2). Because fruit and vegetables represent a large group of foods with varied nutrient and nonnutrient profiles, it is unclear which components of this food group provide protection against CHD. Isothiocyanates are a group of naturally occurring compounds that occur as glucosinolates in cruciferous vegetables, primarily those of the Brassica genus. Isothiocyanates may have beneficial effects on the cardiovascular system, such as inducing detoxifying enzymes and reducing oxidative stress (3–6). Two studies have reported an inverse association between cruciferous vegetable consumption and serum homocysteine concentrations (7, 8), a risk factor for CHD.

Isothiocyanates are rapidly conjugated by glutathione S-transferases (GSTs) and excreted in the urine (9, 10). GSTs are a super-family of xenobiotic-metabolizing enzymes that generally "detoxify" reactive metabolites to more water-soluble and readily excretable forms (11). These enzymes are expressed in several tissues, including the heart and blood vessels (12, 13). GSTs are grouped into several distinct classes with partially overlapping substrate specificities. GSTM1, GSTT1, and GSTP1 are isoforms of the mu, theta, and pi class, respectively. Homozygosity for a common deletion of the GSTM1 gene (GSTM1*0) results in a lack of GSTM1 activity (14). GSTT1 has 2 alleles, denoted GSTT1*0 for the nonfunctional allele and GSTT1*1 for the functional allele (15). An AG polymorphism at nucleotide 313 of GSTP1 results in an amino acid substitution (Ile105Val) in the substrate-binding site of the enzyme. The substitution of the less bulky and more hydrophobic valine results in a substrate-dependent alteration in the catalytic activity of GSTP1 (16, 17). GSTM1 and GSTP1 have been shown to efficiently conjugate various isothiocyanates (9, 18, 19), but less is known about the conjugating capacity or efficiency of the GSTT1 isoform (10, 20).

Despite the evidence suggesting a beneficial effect of cruciferous vegetables or isothiocyanates on the cardiovascular system (3–8), only 2 studies have examined the association between cruciferous vegetable intake and the risk of CHD (21, 22). Neither study found an association between cruciferous vegetables and the risk of CHD. However, an association between isothiocyanates and CHD may have been masked by genetic differences affecting the biotransformation of bioactive compounds such as isothiocyanates. Persons with a GST genotype corresponding to low activity may benefit from the protective effects of isothiocyanates more than would persons with a higher-activity genotype, because these compounds would have a slower rate of biotransformation and subsequent excretion. Alternatively, persons with a functional GST gene may benefit more, because the ability of cruciferous vegetables to induce detoxifying enzymes could facilitate the biotransformation and excretion of harmful substrates such as those found in tobacco smoke. The purpose of the present study was to determine whether GST genotypes modify the association between cruciferous vegetable intake and the risk of MI.


SUBJECTS AND METHODS  
Study design and participants
The catchment area for this study comprised 7071 km2 (2) and 2 057 000 persons living in Costa Rica who self-report as being Hispanic (23). This area included 36 counties in the Central Valley of Costa Rica; the population has a full range of socioeconomic levels and urban, peri-urban, and rural lifestyles. Medical services in this area were covered by 6 large hospitals, which are part of the National Social Security System. Eligible cases were men and women who were survivors of a first acute MI as diagnosed by a cardiologist at any of the 6 recruiting hospitals in the catchment area between 1994 and 2004. To achieve 100% ascertainment of cases, the hospitals were visited daily by the study fieldworkers. All cases were confirmed by 2 independent cardiologists according to the World Health Organization criteria for MI, which require typical symptoms plus either an elevation in cardiac enzyme concentrations or a diagnostic change on electrocardiogram (24). Enrollment was carried out while cases were in their hospital's step-down unit. Cases were ineligible if they died during hospitalization, were 75 y old on the day of their first MI, were physically or mentally unable to answer the questionnaire, or had a previous hospital admission related to cardiovascular disease.

One control for each case, matched for age (± 5 y), sex, and area of residence (county), was randomly selected by using information available at the National Census and Statistics Bureau of Costa Rica. Eligible controls were identified within 1 wk of the case selection. On average, complete data collection took 27 d for cases and 31 d for controls. Because of the comprehensive social services provided in Costa Rica, all persons living in the catchment areas had access to medical care without regard for income. Therefore, controls came from the same source population that gave rise to the cases and are not likely to have had cardiovascular disease that went undiagnosed because of poor access to medical care. Controls were ineligible if they were physically or mentally unable to answer the questionnaires or if they had a previous hospital admission related to cardiovascular disease.

The participation rate for eligible cases and controls was 98% and 88%, respectively. Information on diet was collected, the medical history and anthropometric measurements were collected, and biological specimens were obtained at the subjects' homes.

All cases and controls gave written informed consent. The study was approved by the Ethics Committees of the Harvard School of Public Health and the University of Costa Rica, the Office of Protection from Research Risk at the National Institutes of Health, and the Ethics Review Committee at the University of Toronto.

All data were collected by trained fieldworkers during an interview using 2 questionnaires consisting of closed-ended questions regarding smoking, sociodemographic characteristics, socioeconomic status, physical activity, diet, and medical history, including any use of medication and personal history of diabetes and hypertension. For cases, all data collected represented the year preceding their MI. Dietary intake was collected by using a 135-item semiquantitative food-frequency questionnaire (FFQ) specifically developed and validated to assess dietary intake during the previous year in the Costa Rican population (25). Intakes of nutrients were calculated by using the US Department of Agriculture food composition data file. A commonly used unit or portion size (eg, 1/2 cup broccoli) was specified for each food item, and subjects were asked to choose 1 of 9 categories of intake: never or <1 serving/mo, 1–3 servings/mo, 1 serving/wk, 2–4 servings/wk, 5–6 servings/wk, 1 serving/d, 2–3 servings/d, 4–5 servings/d, or 6 servings/d. Cruciferous vegetable intake was defined as the sum of broccoli, cauliflower, kale, and cabbage intakes and was recalculated relative to 1 serving/d.

Genotyping
Blood samples were collected in the morning at the subject's home after an overnight fast and were centrifuged (1430 x g, 4 min, 20 °C) to separate the plasma and leukocytes for DNA isolation by standard procedures. GSTM1, GSTT1, and GSTP1 genotypes were assayed without knowledge of case or control status by using a previously described multiplex polymerase chain reaction (PCR)–restriction fragment length polymorphism (RFLP) method that simultaneously detects the polymorphisms of all 3 genes in a single reaction (26). Approximately 1 ng DNA was amplified by thermal cycling with the use of the HotStar DNA polymerase kit (Qiagen, Mississauga, Canada) with PCR buffer containing 1.5 mmol MgCl2/L, 0.2 mmol of each dNTP/L, 0.5 U Taq, and 8 pmol of each primer set. GSTM1 primers included forward 5'-CTGCCCTACTTGATTGATC-3' and reverse 5'-CTGGATTGTAGCAGATCATGC-3'. GSTT1 primers included forward 5'-TTCCTTACTGGTCCTCACATCTC-3' and reverse 5'-TCACCGGATCATGGCCAGCA-3'. GSTP1 primers included forward 5'-TCCTTCCACGCACATCCTCT-3' and reverse 5'-AGCCCCTTTCTTTGTTCAGC-3' (26, 27). All primers were synthesized by ACGT (Toronto, Canada).

After an initial denaturation at 95 °C for 15 min, amplification was achieved by using a touchdown PCR protocol with 20 cycles of denaturation at 94 °C for 30 s, at 68–48 °C for 30 s (with a reduction of 1 °C in each cycle), and at 72 °C for 30 s, which were followed by 20 cycles with the annealing temperature set at 51 °C and a final extension at 72 °C for 10 min. After overnight restriction enzyme digestion with 2 U Alw261, PCR products were resolved by 2% agarose gel electrophoresis and stained with ethidium bromide. Bands were visualized by using an ultraviolet imaging system (FluorChem; Alpha Innotech Corp, San Leandro, CA). GSTM1 and GSTT1 genotypes were determined by the presence or absence of a 275-bp (195 + 80 after digestion) or 480-bp band, respectively. Because the GSTM1 fragment contains a nonpolymorphic Alw26I restriction site, the 275-bp band that is amplified is digested into 195-bp and 80-bp fragments in all samples, providing a positive control for complete digestion. The 294-bp band represents GSTP1, and the Ile105Val (AG substitution) polymorphism in this gene introduces an Alw26I restriction site that produces 234-bp and 60-bp bands after digestion. Amplification of GSTP1 also serves as an internal control for the PCRs that have both the homozygous GSTM1*0 and GSTT1*0 genotypes. The GSTP1 genotype distribution among controls was in Hardy-Weinberg equilibrium (P = 0.94). Deviations from Hardy-Weinberg equilibrium were not tested for distributions of GSTM1 and GSTT1 genotypes because the PCR assay does not discriminate heterozygotes from homozygotes for the functional allele. However, frequencies for the GSTM1*0/*0 and GSTT1*0/*0 genotypes were similar to frequencies previously reported in other populations (28–31).

Statistical analysis
All data were analyzed by using SAS software (version 8.2; SAS Institute, Cary, NC). DNA was available from 4369 subjects (2113 cases and 2256 controls). A total of 285 subjects were excluded because they had missing data on confounders (31 cases and 29 controls), they could not be genotyped (39 cases and 47 controls), or they became unmatched because of missing data (1 case and 138 controls); these exclusions left 2042 matched case-control pairs for the final analysis. Dietary variables were adjusted for total energy as described elsewhere (25, 32). Because of the matched design, significant differences in the distribution of categorical variables between cases and controls were tested by using McNemar's test, and significant differences in the distribution of continuous variables were tested by using either a paired t test or Wilcoxon's signed-rank test. Subjects were categorized into low, medium, and high cruciferous vegetable intake categories according to energy-adjusted tertiles of cruciferous vegetable intake created on the basis of the distribution of intake among control subjects. Chi-square tests for categorical variables and analysis of variance (ANOVA) for continuous variables were used to determine significant differences across tertiles of cruciferous vegetable intake among controls.

Categorical and continuous nondietary and energy-adjusted dietary variables were assessed for potential confounding by measuring their effect on the model variable estimates by using the likelihood ratio test. These variables included smoking status (never, past, 1–9 cigarettes/d, or 10 cigarettes/d), alcohol consumption (never, past, or current by tertiles of intake), coffee consumption (1 cup/d, 1 cup/d, 2–3 cups/d, or 4 cups/d), history of diabetes (yes or no), history of hypertension (yes or no), and quintiles of the continuous variables waist-to-hip ratio, physical activity, income, and energy-adjusted intakes of saturated fat, trans fat, polyunsaturated fat, cholesterol, protein and folate. Odds ratios (ORs) and Wald 95% CIs were estimated by using conditional logistic regression to determine the effect of cruciferous vegetable intake and GST genotype on the risk of MI. Genotypes and tertiles of intake were modeled by using indicator variables in logistic models, with the wild-type of each gene or the lowest tertile of intake as the reference. Tests of linear trend across increasing tertiles of cruciferous vegetable intakes were conducted by assigning the medians of intakes in tertiles (servings/d) as a continuous variable. Confounders included in the final models were smoking, alcohol, history of diabetes, history of hypertension, waist-to-hip ratio, physical activity, income, and folate and saturated fat intakes. We evaluated potential gene-diet interactions by determining the relation between tertiles of cruciferous vegetable intake and the risk of MI for each genotype with the use of conditional and unconditional logistic regression (with matching variables in the model) and by comparing –2 log (likelihood) ratios from a model with cruciferous vegetable intakes and gene main effects only with those from another model that included their interaction term. Because results for conditional and unconditional analyses were similar, we report only the data from unconditional analyses to maximize the number of subjects. All statistical analyses were 2-sided, and P values < 0.05 were considered significant.


RESULTS  
Demographic and risk factor characteristics of subjects based on case-control status and data on cruciferous vegetable intake among controls are presented in Table 1. Median cruciferous vegetable intakes for the first (low), second (medium), and third (high) tertiles were 0.08, 0.43, and 0.86 servings/d, respectively. Only high consumption of cruciferous vegetables was associated with a significant reduction in risk of MI. Compared with low cruciferous vegetable intake, the OR (95% CI) of MI associated with medium and high intakes was 0.92 (0.79,1.06) and 0.69 (0.59,0.80), respectively (P < 0.001 for trend). Corresponding multivariate-adjusted ORs (95% CI) were 1.05 (0.88, 1.25) and 0.83 (0.69,0.99) (P = 0.04 for trend).


View this table:
TABLE 1. Demographic and risk factor characteristics by case or control status and cruciferous vegetable intake among controls1

 
The GSTM1*0/*0 genotype occurred in 48% of cases and 51% of controls, and the GSTT1*0/*0 genotype occurred in 19% of cases and 20% of controls. The frequency of the GSTP1 Val allele was 40% for both cases and controls. Compared with the GSTM1*1 allele, the multivariate adjusted OR (95% CI) of MI associated with the GSTM1*0/*0 genotype was 0.86 (0.74, 0.99). Compared with the GSTT1*1 allele, the adjusted OR (95% CI) of MI associated with the GSTT1*0/*0 genotype was 0.99 (0.83, 1.18; NS). Compared with persons with the GSTP1 Ile/Ile genotype, the adjusted OR (95% CI) of MI was 0.99 (0.85, 1.15; NS) for those with the Ile/Val genotype and 0.96 (0.77, 1.18; NS) for those with the Val/Val genotype (P = 0.89 for trend). Similar results were obtained when nonsmokers and current smokers were examined separately (data not shown). The effect of combined genotypes was also examined, but no significant gene x gene interactions were observed (data not shown).

When the association between cruciferous vegetable intake and MI was evaluated by GSTM1, GSTT1, or GSTP1 genotypes (Table 2), a significant GSTT1 x diet interaction was observed. Compared with the lowest level of cruciferous vegetable intake, the adjusted OR (95% CI) for the highest level of intake was 0.70 (0.58, 0.84) in persons with the GSTT1*1 allele and 1.23 (0.83, 1.82; NS) in persons with the GSTT1*0/*0 genotype. No significant interaction between cruciferous vegetable intake and GSTM1 or GSTP1 genotype was observed.


View this table:
TABLE 2. Cruciferous vegetable intake and risk of myocardial infarction by GST genotype

 
In addition to being substrates of GSTs, isothiocyanates are inducers of these enzymes, which enhance the biotransformation and subsequent elimination of mutagens (3). Therefore, we examined whether GST genotypes modify the risk of MI associated with cruciferous vegetable intake separately for nonsmokers and current smokers (Table 3). The protective effect of cruciferous vegetables was greater among current smokers who had the GSTT1*1 allele (OR: 0.54; 95% CI: 0.36, 0.79) than among nonsmokers who had this allele (OR: 0.78; 95% CI: 0.63, 0.98; P = 0.008 for GSTT1 x diet x smoking interaction). Regardless of smoking status, no significant interactions were observed between GSTM1 or GSTP1 genotype and the risk of MI (data not shown). Similar results were observed when data were analyzed separately for men and women (data not shown).


View this table:
TABLE 3. Cruciferous vegetable intake and risk of myocardial infarction by GSTT1 genotype and smoking status

 

DISCUSSION  
Cruciferous vegetables are a rich source of dietary glucosinolates, which are hydrolyzed to biologically active compounds including isothiocyanates. Despite evidence suggesting a protective effect of these compounds on the cardiovascular system (3–6), only 2 studies have examined the association between cruciferous vegetable intake and risk of CHD (21, 22), and neither of those studies found an association. To our knowledge, the present study is the first to examine the association between cruciferous vegetable intake and the risk of MI. Isothiocyanates derived from glucosinolates present in cruciferous vegetables induce GSTs and other enzymes to enhance detoxifying capacity (3–6). After consumption, isothiocyanates are conjugated by GSTs and eliminated. The effect of cruciferous vegetables on CHD may, therefore, be modified by GST genotype.

Because of the biological interaction between GST and isothiocyanates, persons with a functional GSTM1 or GSTT1 allele may benefit more from the detoxifying enzyme–inducing properties of cruciferous vegetables than may persons who lack these alleles. Alternatively, persons with a GST genotype corresponding to low activity may benefit from the protective effects of isothiocyanates more than may those with a higher activity genotype because these compounds could remain in the body longer as a result of a slower rate of biotransformation and subsequent excretion. Our results show a protective effect of cruciferous vegetables only among those with the functional GSTT1*1 allele, which is consistent with the former hypothesis. As a result of cruciferous vegetables inducing the functional GSTT1*1 allele, GSTT1*1 carriers may be more protected against oxidative stress or DNA damage. There is growing evidence that reactive oxygen species and DNA damage caused by mutagens present in the environment or diet play a role in the development of CHD (33, 34). Thus, the importance of GSTT1 in detoxifying mutagenic compounds may be more important than its role in eliminating beneficial compounds such as isothiocyanates. The more pronounced protective effect of cruciferous vegetables that we observed among current smokers is consistent with this hypothesis. It is possible that GSTT1 is not the major GST isoform responsible for the biotransformation of the isothiocyanates present in the cruciferous vegetables commonly eaten in this population. Cruciferous vegetables differ in their composition of glucosinolates (35), which could explain the inconsistency of the effect of GSTT1 genotype on human isothiocyanate metabolism (10, 20). Seow et al (20) reported that persons with the GSTT1*0/*0 genotype excrete isothiocyanates more slowly than do those with the GSTT1*1 allele, whereas no differences were observed between GSTM1 and GSTP1 genotypes. However, Fowke et al (10) examined the same GST isoforms and found a positive association between cruciferous vegetable intake and urinary isothiocyanate excretion only among persons with the GSTP1 Ile/Ile genotype.

In our population, the frequency of the GSTT1*1 allele is 80%. Because the prevalence of this allele has been reported to vary between 36% and 90% (31), future studies examining the association between cruciferous vegetables and risk of CHD should account for genetic differences in GSTT1. A positive association between cruciferous vegetables and risk of CHD may be more evident in populations in whom the GSTT1*1 allele is more common. The significant GSTT1 x diet interaction observed in the current study is not likely to be due to residual confounding. Although variables not accounted for may potentially confound the main effect of cruciferous vegetable consumption on risk of MI, that would not explain the significant protective effect observed in one genotype but not in the other, because a potential confounder is unlikely to be differentially distributed by genotype.

Several studies have examined the effect of GSTT1 genotype on risk of CHD, but the findings have been equivocal (29, 30, 36, 37). None of these studies, however, included data on cruciferous vegetable intake, and substantial differences in the average consumption of these vegetables exist between countries. For example, Chinese Singaporeans consume 1 serving of cruciferous vegetables/d, which is >3 times the average intake of 2 servings/wk in the United States (20, 38). Differences in cruciferous vegetable intake may explain some of the inconsistencies among studies examining GSTT1 genotype and risk of CHD.

The lower risk of MI that we observed with the GSTM1*0/*0 genotype is consistent with 2 previous studies that examined the association between this gene and the risk of MI (30, 36) and with a study reporting a higher proportion of control subjects with a low-activity GSTM1 phenotype than of patients with atherosclerosis (39). Because no GSTM1 x diet interaction was observed in the present study, the role of GSTM1 in isothiocyanate metabolism is unlikely to explain the protective effects of the GSTM1*0/*0 genotype. Furthermore, the role of GSTM1 appears to be unrelated to mutagen detoxification, because we would have expected the GSTM1*0/*0 genotype to be associated with a greater risk among smokers than among nonsmokers. Thus, the lower risk of MI associated with the GSTM1*0/*0 genotype suggests that beneficial compounds—other than isothiocyanates that are metabolized by GSTM1—may protect against MI. In contrast to reports of a protective effect of the GSTM1*0/*0 genotype on risk of MI, other studies have reported either no effect (40) or a greater risk (29, 37) associated with this genotype. Inconsistencies among these studies may be related to the dual role of GSTM1 in eliminating both harmful mutagens from the environment and potentially beneficial compounds found in the diet.

In summary, consumption of cruciferous vegetables was associated with a lower risk of MI only among those with a functional GSTT1*1 allele. These results suggest that cruciferous vegetable intake may protect against MI through the ability of those vegetables to induce detoxifying enzymes. The protective effect of the GSTM1*0/*0 genotype observed in the present study merits further investigation.


ACKNOWLEDGMENTS  
We thank Xinia Siles (project director at the Centroamericano de Poblacion, Universidad de Costa Rica) for directing the data collection and Ana Baylin (Department of Nutrition, Harvard University of Public Health, Boston, MA) for data monitoring and management throughout the study.

The authors' responsibilities were as follows—MCC: completed the genotyping, statistical analysis, and prepared the first draft of the manuscript; AE and HC: obtained funding and provided supervision; and all authors: contributed to the data interpretation and critically revised the manuscript. None of the authors had a personal or financial conflict of interest.


REFERENCES  

Received for publication January 31, 2007. Accepted for publication April 23, 2007.


作者: Marilyn C Cornelis
医学百科App—中西医基础知识学习工具
  • 相关内容
  • 近期更新
  • 热文榜
  • 医学百科App—健康测试工具